药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rescinnamine
Bilastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Panobinostat.
Rescinnamine
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Panobinostat.
Rescinnamine
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Panobinostat.
Rescinnamine
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Panobinostat.
Rescinnamine
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Panobinostat.
Rescinnamine
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Panobinostat.
Rescinnamine
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Panobinostat.
Rescinnamine
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Panobinostat.
Rescinnamine
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Panobinostat.
Rescinnamine
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Panobinostat.
Rescinnamine
Lacidipine
The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Panobinostat.
Rescinnamine
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Panobinostat.
Rescinnamine
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Panobinostat.
Rescinnamine
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Panobinostat.
Rescinnamine
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Panobinostat.
Rescinnamine
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Panobinostat.
Rescinnamine
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Panobinostat.
Rescinnamine
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Panobinostat.
Rescinnamine
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Panobinostat.
Rescinnamine
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Panobinostat.